BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35466171)

  • 21. Serum Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis.
    Kuusela E; Kouri VP; Olkkonen J; Koivuniemi R; Äyräväinen L; Rajamäki K; Valleala H; Nordström D; Leirisalo-Repo M; Ainola M; Eklund KK
    Clin Exp Rheumatol; 2018; 36(5):778-784. PubMed ID: 29600942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
    Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
    J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis?
    Balandraud N; Roudier J; Roudier C
    Semin Arthritis Rheum; 2005 Apr; 34(5 Suppl1):31-3. PubMed ID: 15852253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of SARS-CoV-2 mRNA vaccine on arthritis condition in rheumatoid arthritis.
    Takatani A; Iwamoto N; Koto S; Aramaki T; Terada K; Ueki Y; Kawakami A; Eguchi K
    Front Immunol; 2023; 14():1256655. PubMed ID: 37691925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association analysis of anti-Epstein-Barr nuclear antigen-1 antibodies, anti-cyclic citrullinated peptide antibodies, the shared epitope and smoking status in Brazilian patients with rheumatoid arthritis.
    Yazbek MA; Barros-Mazon Sd; Rossi CL; Londe AC; Costallat LT; Bertolo MB
    Clinics (Sao Paulo); 2011; 66(8):1401-6. PubMed ID: 21915491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered Antibody Response to Epstein-Barr Virus in Patients With Rheumatoid Arthritis and Healthy Subjects Predisposed to the Disease. A Twin Study.
    Svendsen AJ; Westergaard MCW; Draborg AH; Holst R; Kyvik KO; Jakobsen MA; Junker P; Houen G
    Front Immunol; 2021; 12():650713. PubMed ID: 33777048
    [No Abstract]   [Full Text] [Related]  

  • 27. Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system.
    Kano K; Katayama T; Takeguchi S; Asanome A; Takahashi K; Saito T; Sawada J; Saito M; Anei R; Kamada K; Miyokawa N; Nishihara H; Hasebe N
    Neuropathology; 2017 Jun; 37(3):259-264. PubMed ID: 28004435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19, Coronavirus Vaccines, and Possible Association with Lipschütz Vulvar Ulcer: A Systematic Review.
    Vismara SA; Ridolfi A; Faré PB; Bianchetti MG; Lava SAG; Renzi S; Piccoli BTB; Milani GP; Kottanattu L
    Clin Rev Allergy Immunol; 2023 Oct; 65(2):166-171. PubMed ID: 37358748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus and rheumatoid arthritis.
    Balandraud N; Roudier J; Roudier C
    Autoimmun Rev; 2004 Jul; 3(5):362-7. PubMed ID: 15288002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection.
    Miyazaki T; Fujimaki K; Shirasugi Y; Yoshiba F; Ohsaka M; Miyazaki K; Yamazaki E; Sakai R; Tamaru J; Kishi K; Kanamori H; Higashihara M; Hotta T; Ishigatsubo Y
    Am J Hematol; 2007 Dec; 82(12):1106-9. PubMed ID: 17654684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial.
    Araujo CSR; Medeiros-Ribeiro AC; Saad CGS; Bonfiglioli KR; Domiciano DS; Shimabuco AY; Silva MSR; Yuki EFN; Pasoto SG; Pedrosa T; Kupa LVK; Zou G; Pereira RMR; Silva CA; Aikawa NE; Bonfa E
    Ann Rheum Dis; 2022 Jun; 81(6):889-897. PubMed ID: 35193873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update.
    Toussirot E; Roudier J
    Joint Bone Spine; 2007 Oct; 74(5):418-26. PubMed ID: 17625943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute gastrointestinal graft-versus-host disease with cytomegalovirus and Epstein-Barr virus superinfection in a patient with COVID-19.
    Dias E; Marques M; Lopes S; Gullo I; Bastos J; Macedo G
    Rev Esp Enferm Dig; 2023 Feb; 115(2):92-93. PubMed ID: 35748474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-SARS-CoV-2 mRNA vaccines as inducers of humoral response against apolipoprotein A-1?
    Vuilleumier N; Pagano S; Ludewig B; Schmiedeberg K; Haller C; von Kempis J; Rubbert-Roth A
    Eur J Clin Invest; 2022 Feb; 52(2):e13713. PubMed ID: 34841527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
    Mourgues C; Henquell C; Tatar Z; Pereira B; Nourisson C; Tournadre A; Soubrier M; Couderc M
    Joint Bone Spine; 2016 Jul; 83(4):412-5. PubMed ID: 26725744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus and rheumatoid arthritis.
    Balandraud N; Roudier J
    Joint Bone Spine; 2018 Mar; 85(2):165-170. PubMed ID: 28499895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study.
    Berthelot JM; Saulquin X; Coste-Burel M; Peyrat MA; Echasserieau K; Bonneville M; Houssaint E
    J Rheumatol; 2003 Aug; 30(8):1673-9. PubMed ID: 12913921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are Viral Infections Key Inducers of Autoimmune Diseases? Focus on Epstein-Barr Virus.
    Takei M; Kitamura N; Nagasawa Y; Tsuzuki H; Iwata M; Nagatsuka Y; Nakamura H; Imai K; Fujiwara S
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.